Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFARI: Evaluation of Emergency Medication in Children With Food Allergies
NCT07341776Phase 4Recruiting
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, randomised trial in food allergy and anaphylaxis (2 arms). Primary endpoint: Time to complete resolution of allergic symptoms at 24 hours. Started Jan 2026; status: recruiting.
02
Conditions
food allergyanaphylaxis
Beyond the preview
Go deeper on NCT07341776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07341776.